Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Boston Scientific Corporation (BSX) had Revenue of $14.24B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$14.24B
Net Income	$1.57B
Cost of Goods Sold	$4.34B
Gross Profit	$9.89B
Operating Expenses	$11.90B
Operating Income	$2.34B
Non-Operating Income/Expense	$-358.00M
Pre-Tax Income	$1.99B
Normalized Pre-Tax Income	$1.99B
Income after Taxes	$1.59B
Income from Continuous Operations	$1.59B
Consolidated Net Income/Loss	$1.59B
Normalized Income after Taxes	$1.59B
EBIT	$2.34B
EBITDA	$3.60B
Weighted-Average Shares Outstanding (Basic)	1.45B
Weighted-Average Shares Outstanding (Diluted)	1.46B
Earnings per Share (EPS) (Basic)	$1.08
Earnings per Share (EPS) (Diluted)	$1.07
Balance Sheet Financials
Current Assets	$6.51B
Property, Plant, and Equipment	$2.86B
Long-Term Assets	$28.62B
Total Assets	$35.14B
Current Liabilities	$4.93B
Long-Term Debt	$8.57B
Long-Term Liabilities	$10.67B
Total Liabilities	$15.61B
Common Equity	$19.53B
Tangible Shareholders Equity	$-860.00M
Shareholders Equity	$19.53B
Common Shares Outstanding	1.47B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.50B
Cash Flow from Investing Activities	$-2.57B
Cash Flow from Financial Activities	$5.00M
Beginning Cash	$1.13B
End Cash	$1.05B
Increase/Decrease in Cash	$-70.00M
Stock-Based Compensation	$233.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	$-28.00M
Fundamental Metrics & Ratios
Current Ratio	1.32
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.47
Gross Margin	69.49%
Operating Margin	16.45%
EBIT Margin	16.45%
EBITDA Margin	25.26%
Pre-Tax Profit Margin	13.94%
Profit Margin	11.03%
Free Cash Flow	$1.80B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.41
Inventory Turnover	1.75
Receiveable Turnover	6.39
Days Sales in Receivables	57.11
Return on Equity	8.15%
Return on Tangible Equity	-185.12%
Return on Assets	4.53%
Return on Investments	5.67%
Book Value Per Share	$13.32
Free Cash Flow per Share	$1.23
Operating Cash Flow per Share	$1.71

Data from Zacks Investment Research, Inc.